These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16609695

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease.
    Atrian S, López-Viñas E, Gómez-Puertas P, Chabás A, Vilageliu L, Grinberg D.
    Proteins; 2008 Feb 15; 70(3):882-91. PubMed ID: 17803231
    [Abstract] [Full Text] [Related]

  • 4. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease.
    Sinclair GB, Jevon G, Colobong KE, Randall DR, Choy FY, Clarke LA.
    Mol Genet Metab; 2007 Feb 15; 90(2):148-56. PubMed ID: 17079175
    [Abstract] [Full Text] [Related]

  • 5. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system.
    Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, Futerman AH, Aviezer D.
    Plant Biotechnol J; 2007 Sep 15; 5(5):579-90. PubMed ID: 17524049
    [Abstract] [Full Text] [Related]

  • 6. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
    Montfort M, Chabás A, Vilageliu L, Grinberg D.
    Hum Mutat; 2004 Jun 15; 23(6):567-75. PubMed ID: 15146461
    [Abstract] [Full Text] [Related]

  • 7. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
    Hruska KS, LaMarca ME, Scott CR, Sidransky E.
    Hum Mutat; 2008 May 15; 29(5):567-83. PubMed ID: 18338393
    [Abstract] [Full Text] [Related]

  • 8. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM.
    Curr Opin Investig Drugs; 2010 Apr 15; 11(4):472-8. PubMed ID: 20336596
    [Abstract] [Full Text] [Related]

  • 9. Knockdown of chimeric glucocerebrosidase by green fluorescent protein-directed small interfering RNA.
    Campbell TN, Choy FY.
    Genet Mol Res; 2004 Jun 30; 3(2):282-7. PubMed ID: 15266399
    [Abstract] [Full Text] [Related]

  • 10. HIV TAT variants differentially influence the production of glucocerebrosidase in Sf9 cells.
    Vaags AK, Campbell TN, Choy FY.
    Genet Mol Res; 2005 Sep 30; 4(3):491-5. PubMed ID: 16342033
    [Abstract] [Full Text] [Related]

  • 11. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations.
    Alfonso P, Pampín S, Estrada J, Rodríguez-Rey JC, Giraldo P, Sancho J, Pocoví M.
    Blood Cells Mol Dis; 2005 Sep 30; 35(2):268-76. PubMed ID: 16039881
    [Abstract] [Full Text] [Related]

  • 12. Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.
    van Weely S, van den Berg M, Barranger JA, Sa Miranda MC, Tager JM, Aerts JM.
    J Clin Invest; 1993 Mar 30; 91(3):1167-75. PubMed ID: 8450045
    [Abstract] [Full Text] [Related]

  • 13. Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: implications for gene therapy of Gaucher disease.
    Kim EY, Hong YB, Lai Z, Kim HJ, Cho YH, Brady RO, Jung SC.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):381-90. PubMed ID: 15120612
    [Abstract] [Full Text] [Related]

  • 14. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP.
    Pathol Biol (Paris); 2004 Jul 28; 52(6):343-50. PubMed ID: 15261378
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH, Asano N, Ishii S, Ichikawa Y, Fan JQ.
    FEBS J; 2006 Sep 28; 273(17):4082-92. PubMed ID: 16934036
    [Abstract] [Full Text] [Related]

  • 18. Glucocerebrosidase pseudogene variation and Gaucher disease: Recognizing pseudogene tracts in GBA alleles.
    Martínez-Arias R, Comas D, Mateu E, Bertranpetit J.
    Hum Mutat; 2001 Mar 28; 17(3):191-8. PubMed ID: 11241841
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
    Suwannarat P, Keeratichamroen S, Wattanasirichaigoon D, Ngiwsara L, Cairns JR, Svasti J, Visudtibhan A, Pangkanon S.
    Blood Cells Mol Dis; 2007 Mar 28; 39(3):348-52. PubMed ID: 17689991
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.